MedTech Innovation Briefings
Medtech Innovation Briefings provide a description of the medical technology, including its likely place in therapy, the costs of using the technology and a critical review of the strengths and weaknesses of the relevant published evidence. Their purpose is to provide objective information on device and diagnostic technologies to aid local decision-making by clinicians, managers and procurement professionals.
By making this information available, NICE helps to avoid the need for NHS organisations to produce similar information for local use. MIBs are not NICE guidance. They differ in format, contain no judgement on the value of the technology and do not constitute a guidance recommendation. MIBs are developed as part of the NICE Medical Technologies Evaluation Programme (MTEP) .
Products suitable for briefings include:- Those which have a CE mark or equivalent regulatory approval or, Those which approval is expected within 12 months, and are medical devices or diagnostic tests that fall within the scope of the EU Medical Devices and In Vitro Diagnostics directives This includes devices used in social care that are eligible within this definition. Those which have measurable outcomes for the intended patient and system benefit. There should be some data or evidence, relevant to the technology, which can be made publicly available, on the technology to summarise and critically appraise.
Although there is no threshold for the quality or quantity of evidence, the best available evidence will be selected for inclusion. To learn more about the MIBs which have been released and for further information, please visit: www.nice.org.uk/mib Published MIB's Please find the following links to all of the MIS’s published to date.
Click in the links to access the full MIB documentation on the NICE website.
|Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis (MIB93)||January - 2017|
|CentriMag for heart failure (MIB92)||January - 2017|
|Boston Keratoprosthesis Type I for corneal blindness (MIB91)||January - 2017|
|Smartinhaler for asthma (MIB90)||January - 2017|